In adults with autoimmune hypothyroidism, quality of life improved over 12 months whether they took selenium or a placebo, suggesting the improvement was not due to selenium but possibly to other factors like expectation or natural changes in the condition.

Taking 200 micrograms of selenium daily for a year does not improve how people with autoimmune hypothyroidism feel on a standardized quality-of-life survey, even though their thyroid antibody levels decrease.

Taking selenium supplements daily for a year does not lower the amount of levothyroxine that adults with autoimmune hypothyroidism need to take to manage their thyroid hormone levels.

Taking 200 micrograms of selenium daily for a year raises selenium levels in the blood of adults with autoimmune hypothyroidism who are on levothyroxine, but it does not change how efficiently the body converts thyroxine into triiodothyronine.

In people with autoimmune hypothyroidism taking levothyroxine, taking 200 micrograms of selenium daily for a year may lower levels of thyroid peroxidase antibodies by about 19% compared to a placebo, but it does not change the required dose of thyroid hormone or the balance between free triiodothyronine and free thyroxine.

In older adults with low selenium levels, taking selenium and coenzyme Q10 supplements for four years results in a smaller rise in thyroid-stimulating hormone (TSH) levels compared to taking a placebo, and fewer people reach the TSH level that defines subclinical hypothyroidism.